Elizabeth Unni1, Susan Gabriel2, Rinat Ariely3. 1. Roseman University of Health Sciences, South Jordan, Utah. 2. Global Health Economics and Outcomes Research, Teva Pharmaceuticals, Frazer, Pennsylvania. 3. Global Health Economics and Outcomes Research, Teva Pharmaceuticals, Frazer, Pennsylvania. Electronic address: Rinat.Ariely@tevapharm.com.
Abstract
OBJECTIVE: A new generation of digital health technologies (DHT) offers the opportunity to improve adherence and asthma control. Recent literature was reviewed to summarize the use of technological aids and evaluate their impact on health outcomes in patients with asthma. DATA SOURCES: PubMed and Embase were searched to identify articles published over the past 5 years (2013 to 2017). STUDY SELECTIONS: All records were judged for eligibility by 2 independent reviewers; 28 articles met the inclusion criteria. RESULTS: Interactive websites were the most frequently evaluated type of DHT (50% of all studies), followed by mobile apps in adult patient cohorts. Relatively few studies assessed electronic monitoring devices, phone calls, or text messaging. Among the 16 studies that focused on children, most interventions that used interactive websites (n = 8) showed at least some benefit, although results varied based on the specific outcome. Twelve studies focused on adults, with interventions using interactive websites (n = 6) reporting results that were generally less consistent compared with the pediatric studies. The 6 studies that assessed mobile apps with adult patients reported consistent benefits across a range of outcomes, including medication adherence and asthma control. CONCLUSION: Most interventions reported at least some benefit, although results varied based on the specific outcome. Overall, technology that included more interactive features, such as website-based daily diary entries and apps that provided real-time feedback, was associated with increased asthma control, as was the case for multidimensional interventions that combined the use of several complementary types of DHT.
OBJECTIVE: A new generation of digital health technologies (DHT) offers the opportunity to improve adherence and asthma control. Recent literature was reviewed to summarize the use of technological aids and evaluate their impact on health outcomes in patients with asthma. DATA SOURCES: PubMed and Embase were searched to identify articles published over the past 5 years (2013 to 2017). STUDY SELECTIONS: All records were judged for eligibility by 2 independent reviewers; 28 articles met the inclusion criteria. RESULTS: Interactive websites were the most frequently evaluated type of DHT (50% of all studies), followed by mobile apps in adult patient cohorts. Relatively few studies assessed electronic monitoring devices, phone calls, or text messaging. Among the 16 studies that focused on children, most interventions that used interactive websites (n = 8) showed at least some benefit, although results varied based on the specific outcome. Twelve studies focused on adults, with interventions using interactive websites (n = 6) reporting results that were generally less consistent compared with the pediatric studies. The 6 studies that assessed mobile apps with adult patients reported consistent benefits across a range of outcomes, including medication adherence and asthma control. CONCLUSION: Most interventions reported at least some benefit, although results varied based on the specific outcome. Overall, technology that included more interactive features, such as website-based daily diary entries and apps that provided real-time feedback, was associated with increased asthma control, as was the case for multidimensional interventions that combined the use of several complementary types of DHT.
Authors: K Mayoral; O Garin; M A Caballero-Rabasco; M Praena-Crespo; A Bercedo; G Hernandez; J Castillo; C Lizano Barrantes; Y Pardo; M Ferrer Journal: Qual Life Res Date: 2021-01-02 Impact factor: 4.147
Authors: Amy Chan; Anna De Simoni; Vari Wileman; Lois Holliday; Chris J Newby; Claudia Chisari; Sana Ali; Natalee Zhu; Prathima Padakanti; Vasita Pinprachanan; Victoria Ting; Chris J Griffiths Journal: Cochrane Database Syst Rev Date: 2022-06-13
Authors: Rachelle R Ramsey; Jill M Plevinsky; Sophie R Kollin; Robert C Gibler; Theresa W Guilbert; Kevin A Hommel Journal: J Allergy Clin Immunol Pract Date: 2019-12-21
Authors: Petra Svedberg; Susann Arvidsson; Ingrid Larsson; Ing-Marie Carlsson; Jens M Nygren Journal: J Med Internet Res Date: 2019-11-15 Impact factor: 5.428
Authors: Jens Lehmann; Isabel Schreyer; David Riedl; Michael Tschuggnall; Johannes M Giesinger; Marjiana Ninkovic; Marcus Huth; Irmgard Kronberger; Gerhard Rumpold; Bernhard Holzner Journal: BMC Med Inform Decis Mak Date: 2022-03-28 Impact factor: 2.796
Authors: Marcel Braun; Olaf Schmidt; Thomas Schultz; Holger Woehrle; Martina Große Sundrup; Christoph Schöbel Journal: Internist (Berl) Date: 2022-02-18 Impact factor: 0.743
Authors: Blandine Chapel; François Alexandre; Nelly Heraud; Roxana Ologeanu-Taddei; Anne-Sophie Cases; François Bughin; Maurice Hayot Journal: BMC Health Serv Res Date: 2022-08-02 Impact factor: 2.908